Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing.

We have successfully fabricated a dual drug release electrospun scaffold containing an anesthetic, lidocaine, and an antibiotic, mupirocin. Two drugs with different lipophilicities were electrospun from a poly-l-lactic acid (PLLA) solution with a dual spinneret electrospinning apparatus into a single scaffold. The release of the drugs from the scaffold showed different profiles for the two drugs. Lidocaine hydrochloride exhibited an initial burst release (80% release within an hour) followed by a plateau after the first few hours. Mupirocin exhibited only a 5% release in the first hour before experiencing a more sustained release to provide antibacterial action for over 72 h. For comparative purposes, both drugs were spun from a single spinneret and evaluated to determine their release profiles. The scaffold maintained its antibiotic activity throughout the processes of electrospinning and gas sterilization and supported cell viability. It has been reported in the literature that interactions between polymer and drug are known to govern the pattern of drug release from electrospun scaffolds. Here, it was found that the presence of the two drugs in the same polymer matrix altered the release kinetics of at least one drug. Based on the release profiles obtained, the dual spinneret technique was the preferred method of scaffold fabrication over the single spinneret technique to obtain a prototype wound healing device.

[1]  Arturo Valenzuela,et al.  Experimental Studies on the Effect of Lidocaine on Wound Healing , 1998, World Journal of Surgery.

[2]  Karthik Nagapudi,et al.  Engineered collagen–PEO nanofibers and fabrics , 2001, Journal of biomaterials science. Polymer edition.

[3]  R. W. Ross,et al.  Rapid, Modified Kirby-Bauer Susceptibility Test with Single, High-Concentration Antimicrobial Disks , 1973, Antimicrobial Agents and Chemotherapy.

[4]  J. Mccall,et al.  HPLC assay of Lidocaine in plasma with solid phase extraction and UV detection. , 1999, Journal of pharmaceutical and biomedical analysis.

[5]  Boyle Vj,et al.  Rapid, Modified Kirby-Bauer Susceptibility Test with Single, High-Concentration Antimicrobial Disks , 1973 .

[6]  A. Haegerstrand,et al.  Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes , 1993, Agents and Actions.

[7]  Myung-Seob Khil,et al.  Electrospun nanofibrous polyurethane membrane as wound dressing. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[8]  Kwangsok Kim,et al.  Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Lixin Yang,et al.  Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. Leong,et al.  Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. , 2006, Biomaterials.

[11]  G. Wnek,et al.  Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. , 2003, Biomaterials.

[12]  S. Santoyo,et al.  Development and validation of a liquid chromatographic method for in vitro mupirocin quantification in both skin layers and percutaneous penetration studies. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Joel Rosenblatt,et al.  Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[14]  J. Siepmann,et al.  Hydrophilic Matrices for Controlled Drug Delivery: An Improved Mathematical Model to Predict the Resulting Drug Release Kinetics (the “sequential Layer” Model) , 2004, Pharmaceutical Research.

[15]  Yan Li,et al.  A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  L. Miller,et al.  Interpretive criteria for testing susceptibility of staphylococci to mupirocin , 1997, Antimicrobial agents and chemotherapy.

[17]  Lixin Yang,et al.  Biodegradable electrospun fibers for drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Lisbeth Grøndahl,et al.  Controlled release of heparin from poly(ε-caprolactone) electrospun fibers , 2006 .

[19]  V. Meidan,et al.  Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers. , 2003, International journal of pharmaceutics.

[20]  S. Ramakrishna,et al.  Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. , 2005, Biomaterials.

[21]  Hongliang Jiang,et al.  Preparation and characterization of ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-chitosan electrospun membranes , 2004, Journal of biomaterials science. Polymer edition.

[22]  Kam W Leong,et al.  Sustained release of proteins from electrospun biodegradable fibers. , 2005, Biomacromolecules.

[23]  N. Aydın,et al.  Antimicrobial activity of ropivacaine and other local anaesthetics , 2001, European journal of anaesthesiology.

[24]  Shaobing Zhou,et al.  Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation. , 2006, Biomacromolecules.

[25]  Xuesi Chen,et al.  Ultrafine medicated fibers electrospun from W/O emulsions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[26]  J. Kohn,et al.  Comparison of the effect of ethylene oxide and γ-irradiation on selected tyrosine-derived polycarbonates and poly(L-lactic acid) , 1997 .

[27]  E. Entcheva,et al.  Electrospun fine-textured scaffolds for heart tissue constructs. , 2005, Biomaterials.

[28]  R. Boon,et al.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use , 1985, Antimicrobial Agents and Chemotherapy.

[29]  J. Siepmann,et al.  HPMC-Matrices for Controlled Drug Delivery: A New Model Combining Diffusion, Swelling, and Dissolution Mechanisms and Predicting the Release Kinetics , 1999, Pharmaceutical Research.

[30]  A. Goldstein,et al.  Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. , 2006, Biomaterials.

[31]  Won Ho Park,et al.  Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing. , 2006, Biomaterials.

[32]  Darrell H. Reneker,et al.  Beaded nanofibers formed during electrospinning , 1999 .

[33]  A. Popescu,et al.  Wound Pain: A Challenge for the Patient and the Wound Care Specialist , 2004, Advances in skin & wound care.

[34]  John Layman,et al.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[35]  G. Verreck,et al.  The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals. , 2004, Die Pharmazie.